Brace yourselves for the unveiling of Fresenius Medical Care AG's (NYSE: FMS) third quarter financial results on Tuesday 5th November 2024. This eagerly awaited announcement will take place before market open.
the organization is projected to announce an estimated per share $0.38 profit for the quarter, as predicted by financial analysts on Wall Street. Moreover, the company is expected to disclose a total revenue of $5.32 billion for this period.
When examining the earnings report from the corresponding quarter of the previous year, it is evident that the company showcased per-share income of $0.31. This numbers can be credited to the company's total revenue, which amounted to an impressive $5.37 billion during the same quarter.
The company's yearly performance has been analyzed by Wall Street analysts, who have projected a total revenue of $21.05 billion. Moreover, they anticipate the company to disclose profit of $2.52 per share for the fiscal year.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $0.38 | +18.8% | 5.13 B | -2.4% |
| Q1 2024 | $0.36 | +28.6% | 5.13 B | +1.6% |
| Q4 2023 | $0.47 | +6.8% | 5.37 B | +5.3% |
| Q3 2023 | $0.31 | -20.5% | 5.37 B | +4.6% |
| Q2 2023 | $0.32 | -22.0% | 5.26 B | +3.7% |
| *Growth on year-over-year basis | ||||
Fresenius Medical Care AG (FMS) closed Friday's regular trading session at $19.76, showing a 1.13 percent advance. During the day, FMS shares traded between $19.69 and $19.92, with a day volume of 469.60 thousand shares.
